<b>Background</b>: Multiple myeloma (MM) is a hematologic malignancy characterized by clonal plasma cell expansion and diverse genomic rearrangements, including immunoglobulin heavy chain (IGH) translocations. The gene discussed is SLC3A2; the disease is Miyoshi myopathy.